Olga M. Polikutina

Olga M. Polikutina

Auto-generated profile, based on publicly available information

Olga M. Polikutina

Research Institute for Complex Issues of Cardiovascular Diseases

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
AMA. V. Motova
A. V. Motova
VKV. N. Karetnikova
V. N. Karetnikova
AOA. V. Osokina
A. V. Osokina
OPO. M. Polikutina
O. M. Polikutina
OBOlga Barbarash
Olga Barbarash
Purpose. To determine the incidence of type 2 myocardial infarction (MI) diagnosis (according to the Fourth Universal Definition) and the features of patient management in real clinical practice.Material and Methods. A retrospective study was performed by analyzing the case histories of 153 patients diagnosed with acute coronary syndrome (ACS). Inclusion criteria were the presence of ACS at admission followed by a confirmed diagnosis of MI during the hospital period according to the Fourth Universal Definition of MI and the age of patients > 18 years. Patients with severe comorbidities affecting the immediate prognosis and/or being an alternative to the diagnosis of MI were not included in the study.Results. The study showed that emergency coronary angiography was performed in 151 patients (98.7%). A decrease in the renal filtration function in the presence of chronic kidney disease was a contraindication to this study found in 1.3% of cases; 12 (8%) patients did not have coronary artery disease or had stenoses of less than 50%; these patients comprised the group of patients with type 2 MI. While analyzing the results of examination in patients with type 2 MI, ST segment elevation was detected in seven patients (58.4%) according to electrocardiography; ST segment depression was observed in one patient (8.3%); complete left bundle-branch block was found also in 1 case (8.3%), three individuals (25%) did not have any changes in the position of ST segment, but had a negative T wave. Analysis of possible etiological factors in the development of type 2 MI showed the presence of sinus tachycardia in two patients (16.7%), severe sinus bradycardia in one patient (8.3%), fl utter paroxysm and atrial fibrillation with tachysystole throughout the ventricles in two patients (16.7%), and history of atrial fibrillation in one patient (8.3%).Conclusion. Type 2 MI was diagnosed in 8% of patients with ACS with and without ST segment elevation where cardiac arrhythmias including sinus arrhythmias may be the potential etiological factors. Limited capabilities of assessing the stability of atherosclerotic plaque in the coronary artery including that in the presence of plaque thrombosis represent a significant negative factor for establishing diagnosis in routine clinical practice.

11 July 2019 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
SMSergey Mamchur
Sergey Mamchur
EIE. A. Ivanitskiy
E. A. Ivanitskiy
OPO. M. Polikutina
O. M. Polikutina
TCT. Yu. Chichkova
T. Yu. Chichkova
IMI. N. Mamchur
I. N. Mamchur
EKE. A. Khomenko
E. A. Khomenko
Aim. To estimate the efficacy of invasive and non-invasive long-term ECG monitoring in comparison with conventional follow-up for the detection of silent atrial fibrillation (AF)/atrial flutter (AFL)/atrial tachycardia (AT) in patients with a cryptogenic stroke.Methods. The randomized, prospective, two-center study enrolled 36 patients who suffered cryptogenic stroke (CS) or transient ischemic attack (TIA) without past history of AF/AFL/AT. Patients were randomized in a 1:1:1 ratio to one of the three ECG monitoring strategies: standard arrhythmia monitoring (group I, n=12), ECG-monitoring with implantable loop recorder (group II, n=12), and ambulatory noninvasive ECG monitoring (group III, n=12). The primary endpoint was the time to the first detection of AF/AFL/AT. Patients, assigned to the group I, underwent an assessment at scheduled and unscheduled visits and received ambulatory ECG monitoring 28 days and 1 year after randomization. Patients in the group II underwent implantation of Reveal XT (Medtronic, USA) with the daily remote data transmission to CareLink Network. In the group III, for long-term external monitoring, Spyder system (WEB Biotechnology, Singapore) was used for up to 28 days.Results. During the first 28 days of observation, there were no significant differences in AF detection rates between groups I, II, and III: 0 (0%), 1 (8%), and 2 (17%) cases, respectively, р=0.537. During the year of observation, AF/AFL/AT episodes were detected in 1 case (8%) in the group I, 6 cases (50%) in the group II, and 2 cases (17%) in the group III, p=0.0486. The mean time from enrollment into the study to detection of the first AF/AFL/AT episode was 67 days (15; 97) in all groups. In the groups II and III, the first arrhythmia episodes were detected by monitoring devices on days 24 and 6, respectively. In most cases, arrhythmia episodes detected by long-term monitoring were asymptomatic. Recurrent stroke or TIA events occurred in group I and III (1 case in each group), but not in the group with implantable cardiac monitors. Subgroup analysis showed that significantly higher AF/AFL/AT detection rate was associated with stroke, CHA2DS2VASc score ≥2, and the presence of hypertension. For the 12 months of follow-up, the mean AF burden in the group II was 0.4 (0.2; 0.5) hours per day (1.6%). In the patients with recurrent stroke, AF burden was 3.2% compared to 0.9% in the rest of patients.Conclusion. Detection of silent AF with implantable cardiac monitors is superior to standard and long-term external monitoring in cryptogenic stroke patients.

30 June 2018 in PULMONOLOGIYA
Verified
Journal Article
Open access
PDF file
EBEvgeny Bazdyrev
Evgeny Bazdyrev
OPO. M. Polikutina
O. M. Polikutina
YSYu. S. Slepynina
Yu. S. Slepynina
EKE. S. Kagan
E. S. Kagan
KGK. E. Glinchikov
K. E. Glinchikov
OBOlga Barbarash
Olga Barbarash
Цель исследования заключалась в выявлении наиболее значимых факторов неблагоприятного прогноза развития респираторных осложнений (РО) у пациентов с ишемической болезнью сердца (ИБС) после проведения планового коронарного шунтирования (КШ) в условиях искусственного кровообращения. Материалы и методы. В исследование включены пациенты с ИБС (n = 662), рандомизированные в зависимости от наличия заболеваний респираторной системы и вентиляционных нарушений на 3 группы: 1-ю составили 48 (7,2 %) больных с патологией респираторной системы без обструктивных нарушений, 2-ю – 248 (37,5 %) лиц с заболеваниями легких и обструкцией дыхательных путей, 3-ю – 366 (55,3 %) пациентов без заболеваний и инструментальных признаков вентиляционных нарушений. Проведен анализ развития РО в зависимости от исходной функции легких с последующим математическим моделированием прогнозирования данных осложнений. Результаты. Показано, что в раннем послеоперационном периоде РО развились в 73 (11 %) случаях, преимущественно у лиц с признаками бронхообструкции перед операцией. Так, осложнения в данной группе регистрировались в 20,9 % случаев, тогда как при респираторной патологии легких, но без вентиляционных нарушений, они развивались в 2,5 раза реже, а у пациентов с изолированной ИБС – в 4,5 раза реже. С позиции большей значимости риска развития РО из клинико-анамнестических данных выделены такие факторы, как пол и возраст пациента, дооперационные показатели функционального класса стенокардии и хронической сердечной недостаточности, а также наличие в анамнезе постоянной формы фибрилляции предсердий. Более высокий риск развития РО отмечался в том случае, если в предоперационном периоде были получены более низкие значения прогностических параметров, таких как форсированная жизненная емкость легких (ФЖЕЛ), объем форсированного выдоха за 1-ю секунду (ОФВ1), ОФВ1 / ФЖЕЛ и более высокие показатели общей емкости и остаточного объема легких. Установлено также, что изменения уровня функциональной остаточной емкости и диффузионной способности легких, корригированной по уровню гемоглобина, значимого влияния на риск развития данного типа осложнения не оказывали. При наличии хронической обструктивной болезни легких у пациентов с ИБС после КШ закономерно значимо увеличивался риск развития РО. Заключение. Показано, что прогноз развития РО при выполнении КШ у пациентов со стабильной ИБС и обструктивным типом вентиляционных нарушений менее благоприятен. При прогнозировании развития РО показана высокая прогностическая значимость ряда клинико-анамнестических факторов и различные отклонения параметров дыхания (выше или ниже прогностических значений).

1 January 2017 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
OPO. M. Polikutina
O. M. Polikutina
YSYu. S. Slepynina
Yu. S. Slepynina
EBEvgeny Bazdyrev
Evgeny Bazdyrev
OBOlga Barbarash
Olga Barbarash
ИСХОДЫ ЧРЕСКОЖНОГО КОРОНАРНОГО ВМЕШАТЕЛЬСТВА У БОЛЬНЫХ ИНФАРКТОМ МИОКАРДА С ПОДЪЕМОМ СЕГМЕНТА ST И СОПУТСТВУЮЩЕЙ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ

11 June 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
DTD. A. Tsygankov
D. A. Tsygankov
OPO. M. Polikutina
O. M. Polikutina
For many decades, obesity has been one of the main risk factors for cardiovascular disease. Despite medical advances, the obesity increases contribution to morbidity and mortality from cardiovascular diseases. Numerous anthropometric criteria for obesity are well-studied, simple and inexpensive tools for diagnosing overweight in the population. However, their accuracy is comparatively low. In particular, it is impossible to determine body composition based on these criteria, which is a key point in cardiovascular risk stratification. Despite the relatively short period of ultrasound practice for obesity diagnosis, convincing evidence has already been obtained of their high accuracy and effectiveness in predicting the risk of cardiovascular disease. Given the continuous improvement of ultrasound equipment, the studied criteria should be implemented in routine clinical and research practice. This literature review describes the central parameters used in the ultrasound diagnosis of obesity, their contribution to both conventional risk factors and cardiovascular diseases itself.

25 July 2019 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Closed access
PDF file
SMSergey Mamchur
Sergey Mamchur
EKEgor A. Khomenko
Egor A. Khomenko
TCTatiana Y. Chichkova
Tatiana Y. Chichkova
MRMaria P. Romanova
Maria P. Romanova
VEVeronika V. Evtushenko
Veronika V. Evtushenko
OPOlga M. Polikutina
Olga M. Polikutina